Conciseness

The skill is significantly verbose at ~400+ lines. It extensively covers multiple workflows (FDA, EU MDR, global, regulatory intelligence) with tables and templates that repeat information Claude would already know about regulatory affairs. Many tables (e.g., Market Priority Matrix, Notified Body Selection Criteria, Regulatory Monitoring Sources) state obvious considerations. The KPI section, escalation criteria, and related skills table add bulk without actionable value. The document reads more like a regulatory affairs textbook than a concise skill instruction.

Actionability

The skill provides concrete checklists (510(k) submission checklist, MDR Annex II checklist), specific templates with fill-in fields, a substantial equivalence comparison example, and decision frameworks with specific criteria. The regulatory tracker script example with CLI output is a nice touch. However, much of the guidance remains at a procedural level rather than providing truly executable artifacts — the templates are structural outlines rather than copy-paste-ready documents, and the decision trees are ASCII art rather than implementable logic.

Workflow Clarity

Each workflow has numbered steps with a validation checkpoint at the end (e.g., 'Submission accepted; MDUFA date received'). The 510(k) workflow is particularly well-sequenced with clear steps from pathway confirmation through submission. However, most workflows lack intermediate validation/feedback loops — for instance, the MDR workflow doesn't have a 'validate technical documentation completeness before NB submission' checkpoint, and the global workflow lacks checkpoints between market phases. The final validation steps are present but error recovery paths are mostly absent.

Progressive Disclosure

The skill has a clear table of contents, well-organized sections, and references to external files (fda-submission-guide.md, eu-mdr-submission-guide.md, global-regulatory-pathways.md, iso-regulatory-requirements.md) and related skills. The structure appropriately delegates detailed market-specific guidance to reference files. However, no bundle files were provided to verify these references exist, and the main file itself is quite long — some content (like the full regulatory intelligence workflow or the global market access details) could arguably be split into separate files to keep the main skill leaner.

Specificity

Lists multiple specific concrete actions: prepares FDA 510(k)/De Novo/PMA submissions, analyzes regulatory pathways, drafts responses to FDA deficiency letters, develops CE marking documentation under EU MDR 2017/745, coordinates multi-market approval strategies, and maintains regulatory intelligence. Comprehensive coverage of the domain.

Completeness

Clearly answers both 'what' (prepares submissions, analyzes pathways, drafts responses, develops documentation, coordinates strategies) and 'when' with an explicit 'Use when...' clause listing concrete trigger scenarios like planning FDA submissions, navigating 510(k) processes, achieving CE marking, and responding to agency queries.

Trigger Term Quality

Excellent coverage of natural terms users would say: 'FDA', '510(k)', 'PMA', 'CE marking', 'EU MDR', 'medical device', 'pre-submission', 'regulatory strategy', 'deficiency letters', 'Health Canada', 'PMDA', 'NMPA', 'De Novo'. Includes specific regulatory frameworks, agency names, and submission types that users in this domain would naturally reference.

Distinctiveness Conflict Risk

Highly distinctive niche focused specifically on medical device regulatory affairs. The specific regulatory frameworks (510(k), PMA, EU MDR 2017/745), agencies (FDA, PMDA, NMPA), and domain-specific terminology make it extremely unlikely to conflict with other skills.